Literature DB >> 28344165

Mechanisms governing metastatic dormancy in breast cancer.

Jürgen Dittmer1.   

Abstract

Breast cancer is a systemic disease characterized by early dissemination of tumor cells to distant organs. In this foreign environment, tumor cells may stay in a dormant state as single cells or as micrometastases for many years before growing out into a macrometastatic lesion. As metastasis is the primary cause for breast cancer-related death, it is important to understand the mechanisms underlying the maintenance of dormancy and dormancy escape to find druggable targets to eradicate metastatic tumor cells. Metastatic dormancy is regulated by complex interactions between tumor cells and the local microenvironment. In addition, cancer-directed immunity and systemic instigation play a crucial role.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Dormancy; Metastasis

Mesh:

Year:  2017        PMID: 28344165     DOI: 10.1016/j.semcancer.2017.03.006

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  20 in total

1.  Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases.

Authors:  Dipak Panigrahy; Allison Gartung; Jun Yang; Haixia Yang; Molly M Gilligan; Megan L Sulciner; Swati S Bhasin; Diane R Bielenberg; Jaimie Chang; Birgitta A Schmidt; Julia Piwowarski; Anna Fishbein; Dulce Soler-Ferran; Matthew A Sparks; Steven J Staffa; Vidula Sukhatme; Bruce D Hammock; Mark W Kieran; Sui Huang; Manoj Bhasin; Charles N Serhan; Vikas P Sukhatme
Journal:  J Clin Invest       Date:  2019-06-17       Impact factor: 14.808

Review 2.  Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy.

Authors:  D Brooke Widner; Sun H Park; Matthew R Eber; Yusuke Shiozawa
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

Review 3.  Maintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept.

Authors:  Eva Ciruelos; José Manuel Pérez-García; Joaquín Gavilá; Analía Rodríguez; Juan de la Haba-Rodriguez
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

4.  Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion.

Authors:  Ditte Marie Brix; Siri Amanda Tvingsholm; Malene Bredahl Hansen; Knut Bundgaard Clemmensen; Tiina Ohman; Valentina Siino; Matteo Lambrughi; Klaus Hansen; Pietri Puustinen; Irina Gromova; Peter James; Elena Papaleo; Markku Varjosalo; José Moreira; Marja Jäättelä; Tuula Kallunki
Journal:  Oncogene       Date:  2019-01-08       Impact factor: 9.867

5.  The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis.

Authors:  Paola Maroni; Paola Bendinelli; Emanuela Matteucci; Maria Alfonsina Desiderio
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

6.  Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours.

Authors:  Cigdem Selli; Arran K Turnbull; Dominic A Pearce; Ang Li; Anu Fernando; Jimi Wills; Lorna Renshaw; Jeremy S Thomas; J Michael Dixon; Andrew H Sims
Journal:  Breast Cancer Res       Date:  2019-01-07       Impact factor: 6.466

7.  Breast cancer risk in a rapidly aging population: advances and approaches to study the aging tissue microenvironment.

Authors:  Steven J Greco
Journal:  Breast Cancer (Dove Med Press)       Date:  2019-02-19

8.  Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1.

Authors:  Angela Dittmer; Jürgen Dittmer
Journal:  Oncotarget       Date:  2018-04-24

Review 9.  A conduit to metastasis: circulating tumor cell biology.

Authors:  Douglas S Micalizzi; Shyamala Maheswaran; Daniel A Haber
Journal:  Genes Dev       Date:  2017-09-15       Impact factor: 11.361

10.  Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.

Authors:  Yanxia Qin; Kui Chen; Weihong Gu; Xinghua Dong; Ruihong Lei; Yanan Chang; Xue Bai; Shibo Xia; Li Zeng; Jiaxin Zhang; Sihan Ma; Juan Li; Shan Li; Gengmei Xing
Journal:  J Nanobiotechnology       Date:  2018-06-23       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.